Targeted-Immunomodulatory Nanomedicines for the Treatment of Autoimmune Diseases via Multiple Administration Routes
International Journal of Nanomedicine · 2025
DOI: 10.2147/ijn.s558540 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Bom Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Ewha Womans University, Seoul, 03760, South Korea. Hauptthemen laut MEDLINE: Autoimmune Diseases, Nanomedicine, Drug Delivery Systems, Immunomodulating Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Ewha Womans University, Seoul, 03760, South Korea.
- Graduate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul, 03760, South Korea.
- College of Pharmacy, Chosun University, Gwangju, 61452, South Korea.
ORCID-Profile: Jeeeun Yoo, Yonghyun Lee
Zitieren
APA
Lee, B., Yoo, J., Lee, H. S., & Lee, Y. (2025). Targeted-Immunomodulatory Nanomedicines for the Treatment of Autoimmune Diseases via Multiple Administration Routes. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s558540
Vancouver
Lee B, Yoo J, Lee HS, Lee Y. Targeted-Immunomodulatory Nanomedicines for the Treatment of Autoimmune Diseases via Multiple Administration Routes. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s558540
BibTeX
@article{Lee2025,
author = {Lee, Bom and Yoo, Jeeeun and Lee, Han Sol and Lee, Yonghyun},
title = {Targeted-Immunomodulatory Nanomedicines for the Treatment of Autoimmune Diseases via Multiple Administration Routes},
journal = {International Journal of Nanomedicine},
year = {2025},
doi = {10.2147/ijn.s558540}
}
EUVIMED